Home / Stocks / TEVA / Moves / Nov 19, 2026

Why Teva Pharmaceutical Industries (TEVA) stock fell 8.8% on Nov 19, 2026

Teva Pharmaceutical Industries fell 8.8%. Yahoo reported: “Teva Announces R&D Leadership Transition; Eric Hughes to Depart the Company” (5:00 pm ET on Nov 18, 2026). Teva Pharmaceutical Industries also filed an 8-K reporting changes to its directors or officers with the SEC after the Nov 18 close. SPY fell 2.0% and its sector ETF, XLV, fell 2.0%.

The move

TEVA closed down 8.8%.

READINGS ON NOV 19, 2026
Reading (ET)ChangeSPYSector ETF
Close · 4:00 pm-8.8%-2.0%XLV -2.0%

Sources

Valuation before and after

In the weekly snapshot of Nov 16, 2026, TEVA had a Blended P/E of 20.7 against a Normal P/E of 9.3. As of Nov 19, 2026, its Blended P/E is 17.9 against a Normal P/E of 9.3.

Context

This is the first move we have recorded for TEVA.

TEVA stock moves, newest first

What happened next

The question

Why did Teva Pharmaceutical Industries (TEVA) stock fall 8.8% on Nov 19, 2026?

Teva Pharmaceutical Industries fell 8.8%. Yahoo reported: “Teva Announces R&D Leadership Transition; Eric Hughes to Depart the Company” (5:00 pm ET on Nov 18, 2026). Teva Pharmaceutical Industries also filed an 8-K reporting changes to its directors or officers with the SEC after the Nov 18 close. SPY fell 2.0% and its sector ETF, XLV, fell 2.0%.